Because of morpholinos potential for off target effects (Robu et al., 2007; Eisen and Smith, 2008), we sought to confirm the β1AR’s potential involvement in CCM pathogenesis by inactivating adrb1. This evidence concerns the gene ADRB1 and cerebral cavernous malformation.